WordNet

travel or traverse (a distance); "This car does 150 miles per hour"; "We did 6 miles on our hike every day"
the syllable naming the first (tonic) note of any major scale in solmization (同)doh, ut
proceed or get along; "How is she doing in her new job?"; "How are you making out in graduate school?"; "Hes come a long way" (同)fare, make_out, come, get along
create or design, often in a certain way; "Do my room in blue"; "I did this piece in wood to express my love for the forest" (同)make
carry on or function; "We could do with a little more help around here" (同)manage
get (something) done; "I did my job" (同)perform
treat with an agent; add (an agent) to; "The ray dosed the paint"
the quantity of an active agent (substance or radiation) taken in or absorbed at any one time (同)dosage
a measured portion of medicine taken at any one time (同)dosage
a period of seven consecutive days starting on Sunday (同)calendar week
any period of seven consecutive days; "it rained for a week" (同)hebdomad
of or occurring every seven days; "a weekly visit"; "weekly paper" (同)hebdomadal, hebdomadary
a periodical that is published every week (or 52 issues per year)
treated with some kind of application; "a mustache dosed with bear grease"

PrepTutorEJDIC

《疑問文・否定文を作る》 / 《否定命令文を作る》 / 《助動詞とbe動詞のどちらも含まない文に用いて付加疑問を作る》 / 《強意語として》 / 《文》《助動詞とbe動詞のどちらも含まない文に用いて倒置文を作る》 / 《あいづちを打つ場合に》 / 《先行する動詞またはそれを含む述部の代用》 / 《so,nor,neitherで始まる簡略文で》 / …‘を'『する』,行う,果たす / 《通例have done,時にbe doneの形で》…‘を'『終える』,済ませる / …‘を'作る,作り出す / …‘を'『処理する』,整える,片付ける / 〈学課〉‘を'『勉強する』,専攻する / 〈利益・害など〉‘を'与える,もたらす / 〈人〉‘に'『役立つ』,用が足りる(serve) / …の速度で進む,距離を行く / …‘を'見物する / 〈劇〉‘を'上演する;…‘の'役を演じる / …の役目(仕事)をする / 《おもに英》…‘を'だます,かつぐ / 《話》…をへとへとにさせる / 『する』;活動する / 《通例have done,時にbe doneの形で》(…を)『終える』,済ます《+『with』+『名』》 / 〈事が〉『運ぶ』;〈人が〉暮らしていく,健康である / 〈物が〉(…に)『間に合う』,十分である;〈人が〉(…に)役に立つ,向く《+『for』+『名』》 / 《複数形で》すべきこと / 〈C〉《おもに英》大宴会,大パーティー / 〈C〉《英話》詐欺,ぺてん
ド(全音階の第1音)
(おもに飲み薬1回分の)『服用量』 / (痛いこと・いやなことの)1回分,一定量 / (人などが受ける放射線の)線量 / 性病 / (…を)…‘に'投薬する,服用させる《+『名』+『with』+『名』》
〈C〉『週』,(ある日からの)1週間 / (また working week, work week)《a~,the~》(1週間の中の)就業日 / 〈U〉《Wee》(特定の催しが行われる)週間
『毎週の』,1週間(分)の;1週1度の・『毎週』;1週1回・『週刊雑誌(新聞)』

UpToDate Contents

全文を閲覧するには購読必要です。 To read the full text you will need to subscribe.

1. エタンブトール：概要 ethambutol an overview
2. ピラジンアミド：概要 pyrazinamide an overview
3. 非プラチナ製剤ベースの癌化学療法の神経学的合併症の概要 overview of neurologic complications of non platinum cancer chemotherapy
4. 薬物アレルギー患者へのアプローチ an approach to the patient with drug allergy
5. 低用量メトトレキサートの主な副作用 major side effects of low dose methotrexate

English Journal

Efficacy of telaprevir-based therapy in stable liver transplant patients with chronic genotype 1 hepatitis C.

Xavier F1, Didier S2, Mutimer D3, Fagiuoli S4, Navasa M1, Agarwal K5, Berenguer M6, Colombo M7, Herzer K8, Nevens F9, Daems B10, Janssen K10, Ouwerkerk-Mahadevan S10, Kimko H11, Lathouwers E10, Witek J11, Solingen-Ristea RV11.
Annals of hepatology.Ann Hepatol.2016 Jul-Aug;15(4):512-23.
Background and rationale. The REPLACE study (NCT01571583) investigated telaprevir-based triple therapy in patients who have recurrent genotype 1 hepatitis C virus (HCV) infection following liver transplantation and are on a stable immunosuppressant regimen of tacrolimus or cyclosporin A. Patients
PMID 27236150

Feasibility of Pegylated Interferon in Children and Young Adults With Resected High-Risk Melanoma.

Navid F1,2, Herzog CE3, Sandoval J4,5, Daryani VM6, Stewart CF6, Gattuso J7, Mandrell B7, Phipps S8, Chemaitilly W9, Sykes A10, Davidoff AM4,5, Shulkin BL11, Bahrami A12, Furman WL1,2, Mao S10, Wu J10, Schiff D13, Rao B4,5, Pappo A1,2.
Pediatric blood & cancer.Pediatr Blood Cancer.2016 Jul;63(7):1207-13. doi: 10.1002/pbc.25983. Epub 2016 Apr 1.
BACKGROUND: Pegylated interferon α-2b (IFN α-2b) improves disease-free survival in adults with resected stage III melanoma. We conducted a study to determine the feasibility and safety of incorporating pegylated IFN α-2b as adjuvant therapy in the treatment of children and adolescents with high-r
PMID 27038395

In Utero exposure to genistein enhanced intranasal house dust mite allergen-induced respiratory sensitization in young adult B6C3F1 mice.

Guo TL1, Meng AH2.
Toxicology letters.Toxicol Lett.2016 Jun 24;253:17-26. doi: 10.1016/j.toxlet.2016.04.017. Epub 2016 Apr 22.
Despite many hypothesized benefits of dietary isoflavone genistein (GEN) deriving from soy-based products, questions surrounding GEN's developmental immunotoxic effects are increasing. To understand how in utero GEN exposure may modulate postnatal respiratory sensitization, we conducted a time cours
PMID 27113705